Agenus, Inc. (AGEN)
4.15
+0.19
(+4.80%)
USD |
NASDAQ |
Apr 13, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
Agenus Cash from Investing (TTM) : 1.194M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Protalix Biotherapeutics, Inc. | -2.366M |
| CervoMed, Inc. | 18.10M |
| Curis, Inc. | 2.50M |
| Plus Therapeutics, Inc. | -0.854M |
| Windtree Therapeutics, Inc. | -5.972M |